Author:
Coelho Paulo Marcos Z.,Raso Pedro,Mello Rômulo Teixeira de,Toppa Nivaldo H.
Abstract
Mice previously infected with Schistosoma mansoni, and cured by specific treatment (400mg/kg oxamniquine, p. o.) in the chronic phase of the disease, were reinfected 20 days after treatment to assess their capacityfor modulation ofthe granulomatous response. Histopathologic examination of the animals ' liver, at 60 days after reinfection, evidenced the presence of typical granulomas of the chronic phase in most animals. This infer that the capacity for modulation of the granulomatous response had been maintained, thus preventing a new acute phase of the disease. Conversely, a group of previously infected mice, untreated and submitted to reinfection, showed reactivation of the granulomatous response in 50% of the animals. The possible implications of these findings in human schistosomiasis mansoni are discussed.
Subject
Infectious Diseases,Microbiology (medical),Parasitology
Reference30 articles.
1. HLA antigen in schistosomal hepatic fibrosis patients with haematemesis;Abaza H;Tissue Antigens,1985
2. Histocompatibility -linked susceptibility for hepatosplenomegaly in human schistosomiasis mansoni;Abdel-Salam E;Journal of Immunology,1979
3. Curative chemotherapy and resistance to reinfection in murine schistosomiasis;Andrade ZA;The American Journal of Tropical Medicine and Hygiene,1982
4. Mild prolonged schistosomiasis in mice, alterations in host response with time and the development of portal fibrosis;Andrade ZA;Transactions of the Royal Society of Tropical Medicine and Hygiene,1964
5. Schistosoma mansoni: protective immunity in mice cured by chemotherapy at the chronic phase of the disease;Bezerra FSM;Revista do Instituto de Medicina Tropical de São Paulo,1993
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献